Localized amyloidosis ofthe larynx is uncotnm on, accounting fo r fewer than 1% ofall benign laryng eal tumors. We rep ort 2 cases of laryng eal amy loido sis in which dense p lasma eeli injiltrat es were fo und in the vieinity of the amy loid depo sits; in view ofthis finding, we suspected a hematologic dis eas e-s-p las ma cy toma in particulat: Howeve/; mo lecular gen etie analy sis did not demo nstra te any light-chain restriction, indieating tha t theplasma eelis were ofpolyc/onal origin and therefo re eonsistent with chronic irflainmation. We also discuss the available literat ure with resp eet to diagnostic andtherap euticprocedures in p atients with amy loidosis ofthe upp er ainvay.
Introduction
Localized amyloido sis ofthe larynx is uncommon, accounting for fewer than I% of all benign laryngeal tumors.'? In 1875 , Buro w was the first to describ e amy loid depo sits in the larynx.' Since then, num erou s cases of solitary laryngeal amyloidosis have been reported in the literature.v'<In some case s, the c1inical feature s oflaryngeal amyloidosis may lead the c1inician to misdiagnose it as a squamous ce ll carcinorna."
Amyloid is a pathologic protein substance that is deposited between cells in vario us tissues and organs of the body. Approximately 95% of amyloid is made up of fibrillar prot eins , and the remaining 5% is made up of the so-called serum amyloid P component and other glycoproteins." :" Identification of amyloid is based on three criter ia: ( I) Congo red binding and green birefrin gence under polarized light," (2) a fibril structure on electron microscopy," and (3) confirma tion of the characteri stic cross beta-pl eated sheet on x-ray crys tallography and infrared spectroscopy."
Amyloidosis is c1assified on the basis of the amy loid protein's constituent chemic al fibrils. Eighteen bioch emically distinct fonns of amyloid protein have been identified.P The three most comm on are AL, AA, and AB. AL (amy loid immuno globul in [lg] light chain) is derived from plasma cells, AA (seru m amyloid A) is associa ted with chronic inflamm ation, and AB is found in cerebr al lesions in patients with Alzheimer's disease. Amyloidosis can be systemic (generalized) or localized. Clinically, primary amyloidosis is distin guishabl e from secondary amyloidos is.
Most amy loid depo sits in the larynx are oftheAL type. AL deposits appear in both localized and systemic amyloidosis, as weil as in hematol ogic dis ease and in chronic inflamm atory processes. For these reasons, laryngeal amyloidosis should not be considered a single disease; rather, this entity rep resents a group of diseases that have in common a simil ar pattem of prot ein deposition ."
The differential diagno sis of laryn geal tumor-shaped amyloidos is can be problematic for both clinici ans and pathol ogists. In this articl e, we describe 2 cases in which (I ) amyloid depos its were found in mult iple location s in the larynx, (2) there was no evidence of systemic disease, and (3) the po lyclonality of the plasma ce lls indicated the presence of a chronic inflammatory process rather than a so litary extramedullary plasmacytoma.
Case reports
Patient 1. A 54-yea r-old woman was referred to the Department of Otorhinolaryngo logy with a suspected carcinoma of the larynx. She report ed a I-year history of hoarse ness , but no pain or swa llow ing difficult ies. Direet rigid laryngoscopy showed an augmented volume of the left false vocal fold with expansion into the anterior commi ssure (figure I, A). The true voca l folds and their motilit y were not affected c1inically. Computed tomo graphy (CT) of the neek revealed that the false vocal fold s were asymmet rie ( figure 1, B) .
With the patient under general anes thesia, direet laryngoseop y deteeted a reddish swelling of the left false vocal fold. Biopsies were taken and fixed in 10% paraforrnaldehyde . Histologie examin ation revealed the presenee of an amorphous, eosinophilie, hyaline, ext raeellul ar substanee in the subepithe lial laye r that affeeted the supraglottie and glottie laryn x bilaterally, even in areas with an unsuspieious maeroseopie aspeet. Th e Con go-red-stained depo sits refleeted a gree n birefrin genee und er polar ized light, thu s revealing the speeime n's amy loid nature (figure I, C and D). After the amy loid depo sits were treated with KMn0 4 they retained their gree n birefrin genee und er polarized light. Based on this findin g, we considered the possibil-840 ity that the depo sits belonged to the A L amy loid group."
A dense plasm a eeli infiltrate surrounded the amyloid depo sits . Immunohistoehemistry showe d that the plasma eelis synth esized 19 light ehains of the type s kapp a and lambd a in equal numbers. Assessment of IgH gene rearrangement produets usin g genomie DN A obt ained from the form alin-fixed and -emb edded tumor tissue yielded no distinet bands after polymerase ehain reaetion (PCR) amplifieation and eleetrophoretie sepa ratio n. Th is finding impl ied that the plasm a eelis were of polyclonal rather than monoclonal orig in.
To exe lude genera lized amy loidos is, a reetal biopsy, eehoe ardiography, and bron ehoseopy were performed ; they deteeted no pathol ogy. Further diagnostie steps were performed in the Department of Oneology to exclude a plasmacytoma. Findings on bone marrow biopsy were normal, as were the resuits of immunologic laboratory anal ysis , including an assay of8ence Jones proteins. Skeletal roentgenographyrevealed large diploetic vein canals in the skull , but no osteolytic areas. Moreo ver, bone marrow scintigraphy showed only a reduced enhancement of the spine, and therefore there was no evidence ofbone marrow generalization of any malignant disease. In view of the clinic al and histologic amy loid infiltration ofseveral areas ofthe larynx (including the false vocal folds [primarily the left], both true vocal folds , and the laryngeal surface of the epiglottis), any attempt at a curative resection would have been mutilating. Therefore, we decided to perform trimonthly examinations during a 2-year follow -up . At 2 years , no visible increase in residuallaryngeal amyloid had occurred, and the patient exhibited only slight hoarseness and no signs of dyspnea.
Patient 2. In 1995, a 65-year-old man presented to the Department ofOtorhinolaryngology with a 4-week history ofhoarseness and swallowing difficulty. He denied cigarette smoking and alcohol use. Clinical examination revealed the presence ofgranulation tissue on both false vocal folds , although the function ofthe vocal folds themselves was not affected . Direet laryngoscopy was perfonned and multiple biopsies were taken . Histologic analysis revealed the presence of amyloid deposits in all biops y specimens; these depo sits were surrounded by a Iymphocytic plasma eeli infiltrate . Immunohistochemistry and molecular genetic analysis, performed in the manner described in the first case , did not reveal a monoclonal plasma eeli population, which again implied an inflammatory process rather than a Iymphoplasmacytic Iymphoma (immunocytoma).
During the next 7 years, no pro gression of amyloid deposits was evident. In view ofthe absence ofa malignancy and the minor nature ofthe patient's symptoms, no further intervention was necessary.
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However, the patient retumed in 2002 when his persistent hoarseness became aggravated. Laryngoscopy with laser excision biopsies was performed to exclude a malignant process (figure 2). The histologic findings did not differ from those in patient I. Patient 2 underwent the same tests that were performed on patient I to exclude a generalized manifestation of amyloidosis, and, again , all findings were negative.
Management of both patients. Both of these patients were diagnosed with localized amyloidosis of the larynx. 8ecause monoclonality could not be proven and a systemic manifestation of amyloidosis was excluded by skeletal roentgenography and bone marrow biopsy, we excluded a diagnosis of a solitary extramedullary plasmacytoma.
After patient I underwent treatment with a bisphosphonate to preve nt progression of the augmented vo lume of the diploetic emissary canals , no deterioration was observed. The residual local amyloids in the larynx did not increaseo Almost 7 years after patient 2 first underwent his first surgical treatment, new amyloid masses were detected in the larynx . After we ruled out a malignant process, we treated the masses surgically.
Discussion
Localized amyloidosis has been described in the orbit, nasopharynx, lips, parts of the mouth and tongue , larynx, and tracheobronchial tree. 24 • 25 Laryngeal amyloidosis primarily affects men in the fifth decade of'life. ' The nature of symptoms depends on the location ofthe amyloid deposits .' Hoarseness, shortness of breath, and painful deglutition have been described. The predominant symptom of amyloidosis in the glottic area is hoarseness. Our patient 1 complained oflong-standing hoarseness and was referred to our clinic with a suspected laryngeal carcinoma. The fact that amyloidosis can mimic a laryngeal carcinoma has The three common features of all types of amy loid are the typical ultrastructure ofamyloid fibrils as see n on electron microscopy," confirmation ofthe characteristic cross beta-pleated sheet on x-ray crystallography and infrared spectroscopy," and the presence of an amyloi d serum precursor that already has a high deg ree of cross beta-842 pleated sheet structure . Therefore, once amyloid deposits are detec ted, a ge neralized manifestation must be exeluded . If immunohistochemistry reveals anAL type ofamyloid, a diagnosis ofplasmacytom a must be pursued (table) .
Physiologically, kappa and lambda light chains are expressed in a ratio of 3:1. In our patient 1, 19 light chai ns of the kappa and lambda type were equally syn thesized. Th is cou ld suggest a elonai expression ofthe plasma ce lls that secrete 19 light chains of the lamb da type , but the subsequent PCR test could not prove a monoelonality of lam bda-expressing B ce lls. Because no mo noc lonality cou ld be demonstrated on immu nohistochemi stry OI' by molecular genetic methods, a diagnosis of extramedullary plasmacytoma was not confirme d, Therefore, the patient was diag nosed wi th localized amy loidosis of the larynx with po lyelo nal reactive plasma ce ll infiltration . As this case illustrates , the pat hogenesis ofloca l amyloid deposits ofte n remai ns unclear,
The treatme nt ofchoice is management ofthe underlying disease." Therefore, it is impo rtan t to classify amy loidos is correctly. The best treatment for loca lized amyloidosis is local excision." Excision can be performed endoscopically OI' by the laryngofissure procedur e described by Watanabe et al in 1984. 28 In both of our patients, amyloidosis was rest ricted to the larynx, but it affec ted multiple sites there . Th at is why a complete loea l exe isio n was not possible, espeeially in patient 2; the inability to perform surgery exp lains the ree urrenee he experieneed 7 years Iater, In patient I, trimon thly exa minations during a 2-year followup revea led no aggravation, thus confirrning that mutilating surgery is not always indicated. A Iso, generalized amyloidosis did not oee ur in this patien t. Beeause ree urre nee may manifest afte r several years, long-term follow-up is recommended.' and high -grade lymphoma classification is a risk factor for CNS involvement in NH L.12 Lym ph oblastic histology, stage IV disease, and B symptoms are also associa ted with increased risk of CNS disease.l-"
In conclusion, appropriate workup for infectious , congenit al, and other neoplastic causes of a head and neck mass should be addressed first. Howe ver, although rare, it is important to recogn ize perin eural tum or extension along the trig eminal nerve into the crani al vault in the differential diagno sis of a unilateral head and neck mass. MRI is an invaluab le tool in demonstrating both tumor infiltration of the intracranial fossa and peri neur al tumor spread.
